XPRA
CZG
Market cap1.73bUSD
May 05, Last price
1,050.00CZK
Name
Colt CZ Group SE
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Colt CZ Group SE, together with its affiliated companies, operates as a global enterprise specializing in the production, procurement, and distribution of firearms, ammunition products, and specialized tactical gear. Its extensive market reach covers the Czech Republic, the United States, the broader European continent, Africa, Asia, and other international territories. The company offers a diverse array of firearms, encompassing handguns like pistols and revolvers, various rifles including sniper, centrefire, and standard models, as well as submachine guns, machine guns, and grenade launchers. Complementing these weapons, they also provide essential firearm components such as sights, optical mounting solutions, triggers, stocks, grips, and spare parts. Beyond weaponry, Colt CZ Group SE supplies a range of tactical and ballistic equipment, featuring protective items like ballistic vests and helmets, along with combat uniforms and backpacks. Additionally, they offer firearm accessories including handgun holsters, magazine pouches, and slings. The group's activities extend to real estate leasing and the commercial trading of military materials. Its products are marketed and sold under prominent brands, namely Colt, CZ (Ceská zbrojovka), CZ-USA, Colt Canada, Dan Wesson, Brno Rifles, and 4M Systems. These offerings cater to a wide customer base, serving armed forces, military and law enforcement agencies, as well as civilian applications such as personal defense, hunting, and sport shooting. Founded in 1936 and headquartered in Prague, Czech Republic, the company rebranded as Colt CZ Group SE in April 2022, having previously been known as CZG - Ceská zbrojovka Group SE. It operates as a subsidiary under Ceska Zbrojovka Partners SE.
Valuation
Title CZK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||